Laplace raises funding to complete study of tricuspid valve technology
New investors Unorthodox Ventures and Aphelion Cardeation contributed to the funding round.
Therapy Area
FDA approves early feasibility study of Valcare’s transcatheter device
Vivani treats first patient with long-lasting drug implant for weight loss
Proteomics announces Australian launch of predictive diabetic kidney test
Sooma gains FDA approval to commence study of tDCS device
Australia’s TGA approves Body Vision’s AI imaging system
Medtronic announces two-year trial outcomes of Evolut TAVR
Capstan Medical’s robotic platform used for first mitral valve replacements
